Hyderabad: The uncontrolled proliferation of COVID cases....nearly half-a-crore domestically and nearly three crores worldwide indicates the severe spread of the pandemic. The entire humanity is on tenterhooks eagerly waiting for the success of more than 140 on-going experiments in various countries for a proper vaccine. The Oxford vaccine exercise, which successfully passed two stages and is in the most crucial third phase experiment, has encountered an expected stumbling block.
The UK drug giant AstraZeneca and Oxford University have suspended the third phase experiments because a vaccine-induced volunteer developed neurological complications. They have resumed the experiments after an immediate observation by an independent security and review committee. The success of the vaccine depends on the success of the research, which is carried out extensively at various stages and the vaccine should emerge successful at every stage of the research.
Over the years, many scientists have been warning that in view of the several complexities involved it is not easy to design an effective vaccine to gain upper hand on Corona. White House President Trump's accusation that China is hacking into their country's vaccine manufacturing laboratories, Beijing's hasty announcement that health workers can be vaccinated before full approvals arrive, and Russia's preparations for mass vaccination without mention of the third stage....all are creating many doubts on the evolution of the life-saving drug.
Also Read:SII to resume Oxford COVID-19 vaccine trials once DCGI gives nod
Scientists say after the third phase of testing is successfully completed it will take 12-18 months to complete the process of bringing the vaccine to public use. The latest assurance from Astrogene, which aims to make the vaccine available to everyone by the end of this year or, early next year, points to risky haste.